VBContract PerformanceClaims through 2026-09-30 · CY2026
Portfolio
MA Full Risk

Aetna MA Partial Cap

Quality 72 below gate 80 · Spend 6.1% over benchmark

At risk
Attributed lives
2,210
MLR
106.1%
$1188 spend vs $1120 revenue PMPM
Quality score
72
Gate 80
Projected settlement
-$1.8M
Downside exposure $29.7M

Contract terms

Payer
Aetna
Arrangement
Professional cap + Part A surplus
Risk
Full Risk
Period
CY2026
Cap revenue
$1120 PMPM
Surplus share
100%
Quality gate
80

Data completeness

88%

Claims through 2026-09-30. Recent months completed with IBNR estimates.

PMPM spend vs cap revenue

Dashed = IBNR-estimated months

Quality measures

Marker = target
Controlling High BP
61% / 70%
166 gaps
Diabetes HbA1c <9
67% / 75%
97 gaps
Breast Cancer Screening
66% / 74%
79 gaps
Colorectal Screening
59% / 68%
137 gaps
Med Adherence – Statins
81% / 88%
94 gaps

Utilization

Admits / 1000
296
ED / 1000
720
Readmit %
18.9
SNF days / 1000
1520

Risk adjustment

1.12

▼ 0.07 vs prior year (1.19)

RAF drives benchmark / premium — falling RAF shrinks revenue.